Date published: 2025-12-19

1-800-457-3801

SCBT Portrait Logo
Seach Input

P2ry10 Activators

P2RY10 activators encompass a diverse array of chemicals that influence the P2RY10 receptor, a member of the G protein-coupled receptor (GPCR) family. This class of activators operates through various mechanisms to modulate the signaling pathways associated with P2RY10. The primary approach these activators take involves the alteration of intracellular second messenger concentrations, which can lead to an enhancement of the receptor's activity. For instance, certain activators can increase the levels of cyclic AMP (cAMP) within the cell. This is achieved by activating adenylate cyclase, the enzyme responsible for the production of cAMP from ATP. An increase in cAMP can amplify the signaling cascade downstream of P2RY10, assuming the receptor is coupled to cAMP-dependent pathways. Other activators in this category function by inhibiting the breakdown of cAMP and cyclic GMP (cGMP), thereby sustaining or elevating their presence within the cell, which can have an activating effect on the receptor's signaling.

Another mode of action for P2RY10 activators involves the modulation of extracellular nucleotide concentrations. By inhibiting enzymes that degrade extracellular ATP, these activators can cause an accumulation of ATP in the extracellular space, which can then activate P2RY10 if it is sensitive to this molecule. Moreover, some activators interact with other purinergic receptors, which can lead to changes in the purinergic signaling environment and indirectly influence P2RY10 activity. These alterations in the extracellular nucleotide landscape can change the activation profile of P2RY10, as the receptor's function can be modulated by the types and concentrations of ligands available. Additionally, certain activators target the downstream signaling components of the P2RY10 pathway; by modifying the activity of these downstream elements, they can have an impact on the overall signaling output of the receptor, ultimately leading to changes in cellular responses associated with P2RY10 activation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Activates adenylate cyclase, increasing cAMP levels, which could enhance downstream P2RY10 signaling if coupled to cAMP pathways.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$159.00
$315.00
$598.00
34
(1)

Non-specific inhibitor of phosphodiesterases, which increases cAMP and cGMP by preventing their degradation, potentially amplifying P2RY10-mediated signaling.

Sofosbuvir

1190307-88-0sc-482362
25 mg
$143.00
1
(0)

An ecto-ATPase inhibitor, it can increase extracellular ATP levels, which could enhance the activation of P2RY10 receptors sensitive to ATP.

Adenosine-5′-Diphosphate, free acid

58-64-0sc-291846
sc-291846A
sc-291846B
sc-291846C
sc-291846D
sc-291846E
100 mg
500 mg
1 g
10 g
100 g
500 g
$77.00
$180.00
$312.00
$924.00
$4596.00
$9186.00
1
(0)

As a ligand for various P2Y receptors, increased ADP levels, through ectonucleotidase inhibition, could influence P2RY10 signaling.